Therapy News and Research

RSS

Overactive bladder treatments: an interview with Professor Chris Chapple, Consultant Urological Surgeon at the Royal Hallamshire Hospital and Sheffield Teaching Hospitals NHS Foundation Trust

Overactive bladder symptom complex is a symptom complex, the pivotal symptom of which is urgency, which is a compelling desire to pass urine, which is difficult to defer.

1 Oct 2013

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Canada should begin screening 'Baby Boomers' for the hepatitis C virus infection, since this age group is likely the largest group to have the illness, and most don't know they have it, say a group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic. Unlike many other chronic viral infections, early treatment makes hepatitis C curable.

1 Oct 2013

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

1 Oct 2013

Pitt scientists open door to potential research into cures for Parkinson's disease

A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.

1 Oct 2013

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.

1 Oct 2013

New approaches needed for testing cancer drugs

Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalised medicine to patients across Europe, says the European Society for Medical Oncology.

1 Oct 2013

Circassia reports positive results from phase II clinical study of ToleroMune grass allergy treatment

Circassia Ltd, a specialty biopharmaceutical company focused on developing world-class immunotherapies, today announced successful results from a large phase II clinical study of its ToleroMune® grass allergy treatment (Grass-Synthetic Peptide Immuno-Regulatory Epitope [Grass-SPIRE])

1 Oct 2013

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) heard today.

1 Oct 2013

Emotion regulation training enhances efficacy of inpatient cognitive behavioral therapy for MDD

A new psychotherapeutic ingredient, emotion regulation skills training, has been found to enhance standard cognitive behavior therapy for depression in a trial published in the current issue of Psychotherapy and Psychosomatics.

1 Oct 2013

Preoperative statin therapy improves results for isolated CABG and AVR operations

Patients receiving statin therapy before coronary artery bypass grafting (CABG) surgery appear to have a reduced risk of post-surgical mortality, stroke, and atrial fibrillation (irregular or rapid heart rate), according to an article in the October 2013 issue of The Annals of Thoracic Surgery.

1 Oct 2013

Mayo Clinic researchers to develop innovative medical treatments for wounded veterans

Mayo Clinic researchers are part of the second phase of a national consortium that focuses on developing innovative medical treatments for wounded veterans. Mayo's role will emphasize peripheral nerve regeneration.

1 Oct 2013

Researchers develop C6 compound that prevents abnormalities linked with priapism in mice

It's not the little blue pill famous for helping men get big results, but for those who need it, the outcome might be even more significant. A new research report published online in The FASEB Journal, offers hope to men who experience priapism. This condition, which is often seen in men with sickle cell disease, causes erections lasting so long that they cause permanent damage to the penis.

1 Oct 2013

FDA approves Brintellix drug to treat depressive disorder in adults

The U.S. Food and Drug Administration today approved Brintellix (vortioxetine) to treat adults with major depressive disorder.

1 Oct 2013

Study shows young patients are at highest risk of colorectal cancer progression, death

Younger patients with colorectal cancer that has spread to other parts of the body represent a high-risk group that is less likely to respond to treatment. Colorectal cancer in patients younger than 40 is more likely to grow despite treatment and young patients are at greater risk of death than people in other age groups.

1 Oct 2013

Biomedical professor receives 2013 Transformative Research Award from NIH

Cancer researchers have been limited by current imaging technology in their ability to detect not only structure and function of tumors, but also tumor cell circulation. A technology proposed by Lihong Wang, PhD, at Washington University in St. Louis, may hold the key to reaching this goal.

1 Oct 2013

Therapy News and Research

Overactive bladder treatments: an interview with Professor Chris Chapple, Consultant Urological Surgeon at the Royal Hallamshire Hospital and Sheffield Teaching Hospitals NHS Foundation Trust

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

Pitt scientists open door to potential research into cures for Parkinson's disease

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

New approaches needed for testing cancer drugs

Circassia reports positive results from phase II clinical study of ToleroMune grass allergy treatment

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Emotion regulation training enhances efficacy of inpatient cognitive behavioral therapy for MDD

Preoperative statin therapy improves results for isolated CABG and AVR operations

Mayo Clinic researchers to develop innovative medical treatments for wounded veterans

Researchers develop C6 compound that prevents abnormalities linked with priapism in mice

FDA approves Brintellix drug to treat depressive disorder in adults

Study shows young patients are at highest risk of colorectal cancer progression, death

Biomedical professor receives 2013 Transformative Research Award from NIH

Intercalated erlotinib/chemotherapy shows mixed results in NSCLC

Central BP achieves the same with less

Researchers discover how aspirin improves survival in patients with colon cancer

Stem cell-enriched fat grafting may prove an attractive option to major tissue augmentation

Women with recurrent ovarian cancer survive longer after treatment with cediranib

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News